| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/25/1992 | WO1992001469A1 A composition providing improved clearance of bioactive substances from the bloodstream |
| 01/25/1992 | CA2087971A1 Composition providing improved clearance of bioactive substances from the bloodstream |
| 01/22/1992 | EP0467795A2 Dermatological or cosmetic compositions containing vitamin A derivatives |
| 01/22/1992 | EP0467614A1 Pyraxolidinone CCK and gastrin antogonists and pharmaceutical formulations thereof |
| 01/22/1992 | EP0467435A2 Benzhydryl derivatives having calmodulin inhibitor properties |
| 01/22/1992 | EP0467248A2 Pyrazolopyridine compound and processes for preparation thereof |
| 01/22/1992 | EP0466768A1 Short-chain triglycerides. |
| 01/22/1992 | CN1058021A 9-purinyl phosphonic acid derivatives |
| 01/22/1992 | CN1057961A Composition pharmaceutique injectable |
| 01/22/1992 | CA2047327A1 Substituted pyrido-oxazine inhibitors of hmg-coa reductase |
| 01/21/1992 | US5082937 Benzodiazepines and applications in therapeutic practice |
| 01/21/1992 | US5082859 Derivatives of benzocycloalkenyldihydroxyalkanoic acids and medications containing them |
| 01/21/1992 | US5082840 Morpholine compounds and treatment |
| 01/20/1992 | CA2046005A1 Benzhydryl derivatives having calmodulin inhibitor properties |
| 01/18/1992 | CA2046672A1 Pyrazolidinone cck and gastrin antagonists and pharmaceutical formulations thereof |
| 01/18/1992 | CA2035836A1 Reduction of oxyradical damage in biomedical applications |
| 01/17/1992 | WO1992001450A1 Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using |
| 01/15/1992 | EP0465970A1 Substituted pyrrolo-pyridines |
| 01/15/1992 | EP0465550A1 Pharmaceutical lipid composition for parenteral nutrition. |
| 01/15/1992 | EP0465508A1 Dietary supplement for insulin-resistant diabetics |
| 01/14/1992 | WO1992000753A1 PARATHYROID HORMONE ANALOGUES MODIFIED AT POSITIONS 3, 6 or 9 |
| 01/14/1992 | US5081253 Imidazo(4,5-c)pyridines as antiosteoporotic agents |
| 01/14/1992 | US5081136 1,2,3-triazole compounds active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them |
| 01/14/1992 | US5081113 Novel 3-keto-steroids |
| 01/14/1992 | US5081112 Method for treating hyperlipidemia |
| 01/14/1992 | US5081105 Method of treating cancer using structured lipids |
| 01/14/1992 | US5080908 Vitamin b12 composition |
| 01/14/1992 | CA2087190A1 Parathyroid hormone analogues modified at positions |
| 01/14/1992 | CA2046734A1 Substituted pyrrolo-pyridines pharmaceuticals |
| 01/14/1992 | CA1294284C 3-demethylmevalonic acid derivatives, a process for their preparation, pharmaceutical products based on these compounds, their use and intermediates |
| 01/14/1992 | CA1294278C Naphthalene derivative and processes for preparing same |
| 01/14/1992 | CA1294232C Process for preparing glucagon or derivatives or fragments thereof in yeast |
| 01/09/1992 | WO1992000273A1 Orthosubstituted biphenyl amidine and biphenyl guanidine derivatives and antidiabetic or hypoglycaemic agents containing them |
| 01/09/1992 | WO1992000079A1 The use of inositoltrisphosphate for the preparing of medicaments |
| 01/09/1992 | WO1991018027A3 Compounds |
| 01/08/1992 | EP0465364A1 Antiobesity food and method for production thereof |
| 01/08/1992 | EP0465343A1 Pharmaceutical or cosmetical composition comprising a retinoid and a sterol in association |
| 01/08/1992 | EP0465338A1 Process for the preparation of granulates of actives through extrusion |
| 01/08/1992 | EP0465297A1 9-Purinyl phosphonic acid derivatives |
| 01/08/1992 | EP0465265A1 Sulfur-substituted mevinic acid derivatives |
| 01/08/1992 | EP0465096A1 Plasma cholesterol level lowering composition |
| 01/08/1992 | EP0464946A1 5-Isothiazolamine derivates |
| 01/08/1992 | EP0464845A1 Pyrrole derivatives |
| 01/08/1992 | EP0464549A1 Calcitonin analogues and use thereof |
| 01/08/1992 | EP0464521A2 Polysulfide compounds and lipid peroxidation inhibitor containing the polysulfide compounds as active ingredient |
| 01/08/1992 | EP0464022A1 Insulinotropic hormone |
| 01/08/1992 | CN1057649A 2,4-and 2,5-substituted pyridine-n-oxides, process for their preparation and their use |
| 01/07/1992 | US5079245 2-trifluoromethyl-7-substitute-6,7,8,9-tetrahydro-[5H]-benzocycloheptenes |
| 01/07/1992 | CA2046171A1 Sulfur-substituted mevinic acid derivatives |
| 01/04/1992 | CA2045003A1 5-isothiazolamine derivatives |
| 01/03/1992 | WO1992000076A1 Pharmaceutical or cosmetic composition containing a combination of a retinoid and a sterol |
| 01/03/1992 | WO1992000064A1 Process for producing pressed, moulded, delayed release dose units and dose units thus produced |
| 01/02/1992 | EP0463989A1 N-oxyimidic acid derivatives |
| 01/02/1992 | EP0463945A1 Chalcone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 01/02/1992 | EP0463592A1 2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and for their utilization |
| 01/02/1992 | EP0463456A1 Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and their use |
| 01/02/1992 | EP0463154A1 Polypeptide and amino acid based composition |
| 01/02/1992 | EP0463004A1 Metabolic effects of leukaemia inhibitory factor on bone |
| 01/02/1992 | EP0425565A4 Silicon compounds in bone treatment |
| 12/29/1991 | CA2045868A1 2,4- and 2,5-substituted pyridine-n-oxides, processes for their preparation and their use |
| 12/28/1991 | WO1991016914A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof |
| 12/28/1991 | CA2082418A1 Methods and preparations of stable, deodorized oils and pharmaceutical compositions thereof |
| 12/27/1991 | EP0462808A2 Inhibitors of HIV reverse transcriptase |
| 12/27/1991 | EP0462667A2 Beta-lactams as antihypercholesterolemics |
| 12/27/1991 | EP0462556A2 Hypotriglyceridemic use of certain bis(3,5-di-alkyl-4-hydroxphenylthio)methanes |
| 12/27/1991 | EP0462292A1 Salt eliminant composition |
| 12/27/1991 | EP0462291A1 Acat enzyme inhibiting composition |
| 12/27/1991 | EP0462290A1 Lipid absorption inhibiting composition |
| 12/27/1991 | EP0462177A1 Purified insulin mediators and purification process for same |
| 12/27/1991 | CA2045428A1 Method for enhancing the lowering of plasma cholesterol levels |
| 12/26/1991 | WO1991019496A1 Hypolipidemic agent |
| 12/25/1991 | CA2043525A1 Phosphorus-containing hmg-coa reductase inhibitors, new intermediates and method |
| 12/24/1991 | US5075424 Acidification of milk solution, ultrafiltration |
| 12/24/1991 | US5075334 Excretion of potassium ion by prostanoic acid derivatives |
| 12/24/1991 | US5075331 For skin disorders |
| 12/24/1991 | US5075313 For bindign to cholecystokinin receptors |
| 12/24/1991 | US5075311 Hmg-coa reductase inhibiting substituted pryido (2,3-d) pyrimidines |
| 12/24/1991 | US5075302 Treating hypertension, congestive heart failure |
| 12/24/1991 | US5075300 Novel compounds |
| 12/24/1991 | CA1293508C Dihydropyridinelactols, processes for their preparation and their use as medicaments |
| 12/24/1991 | CA1293504C Therapeutic use of tin mesoporphyrin |
| 12/24/1991 | CA1293444C Amino acid chelated compositions for delivery to specific biologicaltissue sites |
| 12/23/1991 | CA2045256A1 Chalcone, their preparation process and the pharmaceutical compositions containing them |
| 12/21/1991 | WO1991019707A2 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
| 12/21/1991 | CA2081577A1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1, 3-benzoxazine-4-ones |
| 12/21/1991 | CA2044906A1 Beta-lactams as antihypercholesterolemics |
| 12/19/1991 | CA2044830A1 Inhibitors of hiv reverse transcriptase |
| 12/18/1991 | EP0462075A2 Use of uridine in the pharmacological treatment of the peripheral complications of diabetes |
| 12/18/1991 | EP0462067A1 Gemfibrozil formulations |
| 12/18/1991 | EP0462066A1 Amorphous gemfibrozil |
| 12/18/1991 | EP0462022A2 Anti-diabetic agents and veterinary anti-diabetic agents |
| 12/18/1991 | EP0462021A2 Cholesterol-lowering agents and veterinary cholesterol-lowering agents |
| 12/18/1991 | EP0461548A2 Method for preventing a second heart attack employing and HMG CoA reductase inhibitor |
| 12/18/1991 | EP0461223A1 Novel 1-triacontanol derivatives |
| 12/17/1991 | US5073574 Tetrazolyl substituted benzonitriles and anti-tumor use thereof |
| 12/17/1991 | US5073568 Antipsoriatic agents |
| 12/17/1991 | US5073567 Milbemycins |
| 12/17/1991 | US5073548 Antiprogestational, progestational and antiglucocorticoid activity; glandular disorders; vision defects; antifertility agents |
| 12/17/1991 | US5073376 Tablets or capsules containing tartaric acid for treatment of metabolic disorders |
| 12/17/1991 | CA1293194C Medicine based on fenofibrate, and a method of preparing it |